Resultats globals: 6 registres trobats en 0.02 segons.
Articles, 6 registres trobats
Articles 6 registres trobats  
1.
24 p, 1.1 MB Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019 : Benefits and risks of antithrombotic therapy for cardiovascular disease prevention / Walker, Jaqui (International Aspirin Foundation) ; Cattaneo, Marco (Università degli studi di Milano) ; Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ; Agnelli, Giancarlo (University of Perugia) ; Chan, Andrew T. (Harvard Medical School) ; Lanas, Angel (Universidad de Zaragoza) ; Rocca, Bianca (Catholic University School of Medicine) ; Rothwell, Peter (Centre for the Prevention of Stroke and Dementia) ; Patrignani, Paola ('G.d'Annunizio' University) ; Langley, Ruth (MRC Clinical Trials Unit at UCL) ; Vilahur, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Cosentino, Francesco (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Universitat Autònoma de Barcelona
At the 2019 International Aspirin Foundation Scientific Conference 'Benefits and Risks of Antithrombotic Therapy for Cardiovascular Disease Prevention', held in Rome, Italy, international experts sought to discuss and debate the optimal antithrombotic strategy for the secondary prevention of cardiovascular disease (CVD) and to seek agreement around dosing and target populations for aspirin use in primary disease prevention. [...]
2020 - 10.3332/ECANCER.2019.998
ecancermedicalscience, Vol. 14 (13 2020) , p. 998  
2.
7 p, 468.8 KB ABCB1 Genetic Variants as Predictors of Irinotecan-Induced Severe Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients / Riera, Pau (Institut d'Investigació Biomèdica Sant Pau) ; Artigas-Baleri, Alícia (Institut d'Investigació Biomèdica Sant Pau) ; Salazar, Juliana (Institut d'Investigació Biomèdica Sant Pau) ; Sebio, Ana (Institut d'Investigació Biomèdica Sant Pau) ; Virgili Manrique, Anna Cristina (Institut d'Investigació Biomèdica Sant Pau) ; Arranz, María Jesús (Fundació Docència i Investigació Mútua Terrassa) ; Páez, David (Instituto de Salud Carlos III) ; Universitat Autònoma de Barcelona
Irinotecan is widely used in the treatment of metastatic colorectal cancer (mCRC) despite its severe toxicities. Toxicity is often associated with the UGT1A1*28/*28 genotype. An explanation for idiopathic toxicity beyond the UGT1A1 biomarker, however, remains a major concern for clinicians. [...]
2020 - 10.3389/fphar.2020.00973
Frontiers in Pharmacology, Vol. 11 (30 2020) , p. 973  
3.
21 p, 1.3 MB Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity / Velasco, Roser (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Alemany, Montserrat (Institut d'Investigació Biomèdica de Bellvitge) ; Villagrán, Macarena (Institut d'Investigació Biomèdica de Bellvitge) ; Argyriou, Andreas A. (Neurology Department, "Saint Andrew's" State General Hospital of Patras)
Oxaliplatin (OXA) is a platinum compound primarily used in the treatment of gastrointestinal cancer. OXA-induced peripheral neurotoxicity (OXAIPN) is the major non-hematological dose-limiting toxicity of OXA-based chemotherapy and includes acute transient neurotoxic effects that appear soon after OXA infusion, and chronic non-length dependent sensory neuronopathy symmetrically affecting both upper and lower limbs in a stocking-and-glove distribution. [...]
2021 - 10.3390/jpm11070669
Journal of personalized medicine, Vol. 11 (july 2021)  
4.
5 p, 637.4 KB Educational needs in gastrointestinal cancer : a consensus position paper from the ESMO Gastrointestinal Cancer Faculty / Lordick, Florian (Leipzig University Medical Center) ; Obermannova, Radka (Masaryk University) ; Vola, Doris (European Society for Medical Oncology) ; Douillard, Jean-Yves (European Society for Medical Oncology) ; Mcgregor, Keith (European Society for Medical Oncology) ; Van Cutsem, Eric (University Hospitals Leuven (Bèlgica)) ; Tabernero, Josep (Universitat Autònoma de Barcelona) ; Ciardiello, Fortunato (Second University of Naples) ; Cervantes, Andrés (Universitat de València)
Gastrointestinal (GI) cancers are common in all parts of the world. Effective prevention and early detection of GI cancers are not universally implemented. Therefore, it must be anticipated that the incidence and the mortality of GI cancers will remain high within the next decades. [...]
2019 - 10.1136/esmoopen-2019-000533
ESMO open, Vol. 4 (july 2019)  
5.
9 p, 403.1 KB Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors : a population-based study / Rubió Casadevall, Jordi (Institut Català d'Oncologia) ; Borràs, Joan Lluis (Hospital Universitari Sant Joan de Reus (Tarragona)) ; Carmona-Garcia, M. Carmen (Institut d'Investigació Biomèdica de Girona) ; Ameijide, Alberto (Universitat Rovira i Virgili. Fundació per a la Investigació i Prevenció del Càncer) ; Gonzalez-Vidal, Allan (Institut d'Investigació Biomèdica Sant Pau) ; Ortiz, Maria Rosa (Hospital Universitari de Girona Doctor Josep Trueta) ; Bosch Príncep, Ramon (Hospital de Tortosa Verge de la Cinta) ; Riu, Francesc (Hospital Universitari Sant Joan de Reus (Tarragona)) ; Parada, David (Hospital Universitari Sant Joan de Reus (Tarragona)) ; Martí, Esther (Hospital Sant Pau i Santa Tecla (Tarragona)) ; Miró, Josefina (Clinica Girona Departament de Patologia) ; Sirvent, Juan Jose (Hospital Universitari Joan XXIII de Tarragona) ; Galceran, Jaume (Red Temática de Investigación Cooperativa en Cáncer (RTICC), Girona, Spain) ; Marcos-Gragera, Rafael (Institut d'Investigació Biomèdica de Girona) ; Universitat Autònoma de Barcelona
Gastrointestinal stromal tumors are sarcomas of the digestive tract characterized by mutations mainly located in the c-KIT or in the platelet-derived growth factor receptor (PDGFR)-alpha genes. Mutations in the BRAF gene have also been described. [...]
2015 - 10.1186/s12957-015-0474-0
World Journal of Surgical Oncology, Vol. 13 (february 2015)  
6.
15 p, 3.0 MB Epigenetic inactivation of the extracellular matrix metallopeptidase ADAMTS19 gene and the metastatic spread in colorectal cancer / Alonso, Sergio (Institut Germans Trias i Pujol. Institut de Medicina Predictiva i Personalitzada del Càncer) ; González Fernández, Beatriz (Institut Germans Trias i Pujol. Institut de Medicina Predictiva i Personalitzada del Càncer) ; Ruiz-Larroya, Tatiana (Institut Germans Trias i Pujol. Institut de Medicina Predictiva i Personalitzada del Càncer) ; Durán Domínguez, Mercedes (Instituto de Biología y Genética Molecular (Valladolid)) ; Kato, Takaharu (Institut Germans Trias i Pujol. Institut de Medicina Predictiva i Personalitzada del Càncer) ; Matsunaga, Akihiro (Sanford Burnham Prebys Medical Discovery Institute (Califòrnia)) ; Suzuki, Koichi (Jichi Medical University (Japó)) ; Strongin, Alex Y. (Sanford Burnham Prebys Medical Discovery Institute (Califòrnia)) ; Giménez Bonafé, Pepita (Institut Germans Trias i Pujol. Institut de Medicina Predictiva i Personalitzada del Càncer) ; Perucho, Manuel (Institut Germans Trias i Pujol. Institut de Medicina Predictiva i Personalitzada del Càncer)
BACKGROUND: ADAMTS19 encodes a member of the ADAMTS (a disintegrin and metalloproteinase domain with thrombospondin motifs) protein family with emerging roles in carcinogenesis and metastasis. ADAMTS shares several distinct protein modules including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. [...]
2015 - 10.1186/s13148-015-0158-1
Clinical Epigenetics, Vol. 7, No. 124 (December 2015)  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.